Previous 10 | Next 10 |
Many investors have been worried about the Nasdaq Composite (NASDAQINDEX: ^IXIC) lately. The index has taken a leadership role during 2020's huge rebound from the coronavirus bear market, but its steep decline in early September made some believe that the best of times for the Nasdaq were no...
Marinus Pharmaceuticals (NASDAQ: MRNS ) +61% after ganaxolone successful in pivot study in rare type of epilepsy. More news on: Marinus Pharmaceuticals, Inc., Plus Therapeutics, Inc., Tiziana Life Sciences PLC, Stocks on the move, , Read more ...
List Of Penny Stocks Making Aftermarket Moves On Monday Are you putting together a list of penny stocks for Tuesday? If you said yes, you’re not alone. There are plenty of traders looking to gain the edge when it comes to “getting in early”. Getting at the lowest low and...
Marinus Pharmaceuticals (NASDAQ: MRNS ) announces positive results from a Phase 3 clinical trial, MARIGOLD , evaluating lead drug ganaxolone in children and young adults with a rare inherited type of epilepsy with treatment-resistant seizures called CDKL5 deficiency disorder (CDD), a ...
Trial met primary endpoint, median 28-day major motor seizure frequency reduction of 32.2 percent compared to 4.0 percent for placebo (p=0.002) Ganaxolone was generally well tolerated and the discontinuation rate in the active treatment arm was less than 5 percent New Drug Applicat...
For supporting the development of IV ganaxolone for the treatment of refractory status epilepticus (RSE), Marinus Pharmaceuticals (NASDAQ: MRNS ) +11.5% PM , entered into a five year development contract with the Biomedical Advanced Research and Development Authority (BAR...
Immunomedics (NASDAQ: IMMU ) +106% after Gilead to buy the company for $21B (~$88/share). More news on: Immunomedics, Inc., Cassava Sciences, Inc., China Natural Resources, Inc., , Stocks on the move, Read more ...
BARDA to fund up to $51 million of $84 million contract for programs related to refractory status epilepticus (RSE) development Five-year contract supports clinical development of IV ganaxolone for treatment of RSE, including treatment of individuals exposed to nerve gas BARDA will...
These 4 Penny Stocks Can Be Bought For Under $4 Right Now; Are They Worth It? What is a penny stock ? Well, when it comes to the world of cheap stocks, penny stocks are simply those that are trading below $5 per share. While some traders have their own definitions of what a penny stock is, ...
There’s Blood In The Streets But Not For These Penny Stocks Today Are you looking for penny stocks to buy now? If so, you’re not alone but a big question being asked right now is “When will stocks go back up?” The last two days of market turmoil have sparked a m...
News, Short Squeeze, Breakout and More Instantly...
Marinus Pharmaceuticals Inc. Company Name:
MRNS Stock Symbol:
NASDAQ Market:
Marinus Pharmaceuticals Inc. Website:
Marinus Pharmaceuticals , Inc. (Nasdaq:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it plans to release financial results for the second quarter ended June 30, 2024 on August 13, 2024. The Company will h...
MRNS Investors Have Opportunity to Lead Marinus Pharmaceuticals, Inc. Securities Lawsuit Filed by the Schall Law Firm PR Newswire LOS ANGELES , July 24, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing ...
Marinus Pharmaceuticals , Inc. (Nasdaq:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that the China National Medical Products Administration (NMPA) has approved ganaxolone oral suspension for the treatment of ...